NEW YORK, June 2, 2026 – IBM's stock took a breather on Tuesday, slipping 0.4% to $319.10 by late morning, after surging to an intraday high of $327.22. The pullback came as investors digested a flurry of catalysts that had propelled the shares into momentum territory over the prior two sessions, including a major quantum computing investment, a bullish analyst call, and a spike in retail trading activity. At current levels, the company's market capitalization stands around $304 billion.
The rally reflected a broader shift in how the market views IBM, which is now seen as a rare convergence point for three key U.S. market themes: enterprise artificial intelligence infrastructure, federal industrial policy, and the long-term potential of quantum computing. The stock's recent gains were the largest two-day percentage increase since at least the early 1970s, according to FactSet data cited by Axios, underscoring the intensity of the move.
Quantum Computing Investment
IBM announced plans to spend over $10 billion on quantum computing over the next five years, allocating funds to research and development, manufacturing, capital expenditures, partnerships, and potential acquisitions. The investment supports the company's push toward IBM Quantum Starling, a fault-tolerant quantum computer targeted for 2029. CEO Arvind Krishna stated, "The quantum era is no longer ahead of us," as the company has already deployed over 90 quantum systems and booked more than $1.1 billion in quantum contracts since 2017, with over 340 members in its IBM Quantum Network.
Federal Funding and Foundry
In a separate development, IBM and the U.S. Commerce Department signed a letter of intent last month to establish Anderon, a new standalone IBM company that will operate the first U.S. quantum wafer foundry. The project is expected to receive $1 billion in CHIPS Act funding, with IBM contributing an additional $1 billion. Commerce Secretary Howard Lutnick emphasized that "American quantum capabilities" will advance with these investments, signaling strong government support for domestic quantum manufacturing.
Analyst Upgrade
Barclays analyst Raimo Lenschow initiated coverage of IBM with an Overweight rating and a $350 price target. Lenschow highlighted the company's software business as the core driver, describing IBM as a "stable earnings compounder with a quantum option." This assessment suggests that while quantum computing offers upside potential, the near-term valuation rests on the strength of its software and consulting operations.
Nvidia Partnership
IBM also gained attention after being named a partner for Nvidia's Vera Rubin AI accelerators, as reported by StockStory on Yahoo Finance. IBM's role includes system building, cloud services, and secure storage infrastructure. The partnership builds on an earlier March announcement to expand collaboration on GPU-native analytics, unstructured data, and regulated infrastructure. Nvidia CEO Jensen Huang remarked that IBM is "redefining it for the AI era."
Retail Trading Surge
The rally drew significant retail interest, with call-option buying spiking and Reddit chatter increasing, according to Axios. A resurfaced video of President Trump praising Krishna and suggesting IBM's stock could rise further added to the momentum, though the Trump Organization clarified that neither Trump, his family, nor the company controls specific investments. However, Tuesday's pause indicates that retail flows can quickly reverse.
Risks and Outlook
Despite the optimism, risks remain. Quantum computing technology still faces high error rates, and the Anderon foundry has yet to finalize definitive agreements. If IBM's software growth fails to support its valuation, or if quantum spending remains largely hype-driven, the rally could stall. Competitors like D-Wave and Rigetti are also set to receive approximately $100 million each from government funding, while Infleqtion CEO Matthew Kinsella noted that quantum computing is "coming much faster than anybody thinks."
For now, IBM stands at the intersection of enterprise AI, federal policy, and quantum potential, but the path forward depends on execution and market confidence in its long-term strategy.
